Antibodies to β2-glycoprotein I - A specific marker for the antiphospholipid syndrome

Clinical and Experimental Immunology

Volumn 109, Issue 2, 1997, Pages 304-309

  Guerin, J ^a   Feighery, C ^a   Sim, R B ^b   Jackson, J ^a,c  

^a ST JAMES S HOSPITAL   (Ireland)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

Author keywords

Antiphospholipid syndrome; Cardiolipin; ELISA; Thrombosis; 2 glycoprotein I

Indexed keywords

AUTOANTIBODY; BETA2 GLYCOPROTEIN 1; CARDIOLIPIN; BIOLOGICAL MARKER; CARDIOLIPIN ANTIBODY; DIAGNOSTIC AGENT; GLYCOPROTEIN; MEMBRANE PROTEIN;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTIOUS MONONUCLEOSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SYPHILIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS; CEREBROVASCULAR DISEASE; COMPARATIVE STUDY; IMMUNOLOGY; LABORATORY DIAGNOSIS; METHODOLOGY;

ANTIBODIES, ANTICARDIOLIPIN; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; BIOLOGICAL MARKERS; CEREBROVASCULAR DISORDERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE REACTIONS; GLYCOPROTEINS; HIV INFECTIONS; HUMANS; INFECTIOUS MONONUCLEOSIS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MEMBRANE GLYCOPROTEINS; SYPHILIS;

EID: 0030610376     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.4601357.x     Document Type: Article

References (36)

1. McNeil HP, Chesterman CN, Krilis SA. Immunology and clinical importance of antiphospholipid antibodies. Adv Immunol 1991; 49:193-280.
2. Costello PB, Green FA. Reactivity patterns of human anticardiolipin and other antiphospholipid antibodies in syphilitic sera. Infect Immunol 1986; 51:771-5.
3. Santiago MB, Cossermelli W, Tuma MF et al. Anticardiolipin antibodies in patients with infectious diseases. Clin Rheumatol 1989; 8:23-28.
4. Harris EN, Gharavi AE, Hughes GRV. Anti-phospholipid antibodies. Clin Rheum Dis 1985; 11:591-608.
5. Triplett DA. Coagulation assays for the lupus anticoagulant: review and critique of current methodology. Stroke 1992; 23:I-11-I-14.
6. Reber G, Arvieux J, Comby E et al. Multicenter evaluation of nine commercial kits for the quantitation of anticardiolipin antibodies. Thromb Haemos 1995; 73:444-52.
7. Galli M, Comfurius P, Maassen C et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin hut to a plasma protein cofactor. Lancet 1990; 335:1544-7.
8. McNeil HP, Simpson RJ, Chesterman CN, Krilis SA. Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: β2-glycoprotein 1 (apolipoprotein H). Proc Natl Acad Sci USA 1990; 87:4120-4.
9. Matsuura E, Igarashi Y, Nagae H et al. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 1990; 336: 177-80.
10. Schousboe I. Beta 2-glycoprotein I: a plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway. Blood 1985; 66:1086-91.
11. Nimpf J, Wurm H, Kostner GM. Beta 2-glycoprotein 1 (apo-H) inhibits the release reaction of human platelets during ADP-induced aggregation. Atherosclerosis 1987; 63:109-14.
12. Nimpf J, Bevers EM, Bomans PH et al. Prothrombinase activity of human platelets is inhibited by beta 2-glycoprotein I. Biochem Biophys Acta 1986; 884:142-9.
13. Kroll J, Laron JK, Loft H et al. DNA-binding protein in Yoshida ascites tumour fluid. Biochem Biophys Acta 1976; 434:490-501.
14. Polz E. Isolation of a specific lipid binding protein from human serum by affinity chromatography using heparin-Sepharose. In: Peeters H, ed. Protides of biological fluids. Oxford: Pergamon Press, 1979:817-20.
15. Matsuura E, Igarashi Y, Fujimoto M et al. Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor. J Immunol 1992; 148:3885-91.
16. 2-glycoprotein I contains a phospholipid binding site (cys281-cys288) and a region recognized by anticardiolipin antibodies. J Immunol 1994; 152:653-8.
17. Alarcon-Segovia D, Sanchez-Guerrero J. Primary antiphospholipid syndrome. J Rheumatol 1989; 16:482-8.
18. Maclean C, Flegg PJ, Kilpatrick DC. Anti-cardiolipin antibodies and HIV infection. Clin Exp Immunol 1990; 81:263-6.
19. LeFrere JJ, Gozin D, Modai J. Circulating anticoagulants in acquired immunodeficiency syndrome. Ann Intern Med 1987; 107:429-30.
20. Loizou S, Mackworth-Young CG, Cofiner C, Walport MJ. Heterogeneity of binding reactivity to different phospholipids of antibodies from patients with systemic lupus erythematosus (SLE) and with syphilis. Clin Exp Immunol 1990; 80:171-6.
21. Stasi R, Stipa E, Masi M et al. Antiphospholipid antibodies: prevalence, clinical significance and correlation to cytokine levels in acute myeloid leukaemia and non-Hodgkin's lymphoma. Thromb Haemos 1993; 70:568-72.
22. Lockwood CJ, Romero R, Feinberg RF et al. The prevalence and biologic significance of lupus anticoagulant and cardiolipin antibodies in a general obstetric population. Am J Obstet Gynecol 1989; 161:369-73.
23. Canosa RT, Sise HS. Chlorpromazine-induced lupus anticoagulant and associated immunologic abnormalities. Am J Haematol 1982; 13:121-9.
24. Asherson RA, Cervera R. The antiphospholipid syndrome: a syndrome in evolution. Ann Rheum Dis 1992; 51:147-50.
25. Sohngen D, Wehmeier A, Specker C, Schneider W. Antiphospholipid antibodies in systemic lupus erythematosus and Sneddon's syndrome. Sem Thromb Haemos 1994; 20:55-63.
26. 2-glycoprotein I as an antigen. J Immunol Methods 1991; 143:223-9.
27. 2-glycoprotein-I assay for discrimination between anticardiolipin antibodies associated with infection and increased risk of thrombosis. Br J Haematol 1995; 91:471-3.
28. 2-glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus. Arthritis Rheum 1996; 39:1466-74.
29. 2-glycoprotein I and a conventional anticardiolipin ELISA. Arthritis Rheum 1996; 39: 1606-7.
30. 2-glycoprotein I in the absence of phospholipid. J Immunol 1995; 154:954-60.
31. 2 glycoprotein I antibodies: detection and association with thrombosis. Br J Haematol 1995; 89:397-402.
32. 2 glycoprotein I and anticardiolipin antibodies. J Rheumatol 1995; 22:2233-7.
33. 2-glycoprotein I structure altered by interacting with an oxygen-modified solid phase surface. J Exp Med 1994; 179: 457-62.
34. Colaco CB, Male DK. Antiphospholipid antibodies in syphilis and a thrombotic subset of SLE-distinct profiles of epitope specificity. Clin Exp Immunol 1985; 59:449-6.
35. Rubbert A, Bock E, Schwab J et al. Anticardiolipin antibodies in HIV infection: association with cerebral perfusion defects as detected by 99mTc-HMPAO SPECT. Clin Exp Immunol 1994; 98:361-8.
36. Triplett DA. Lupus anticoagulants/antiphospholipid-protein antibodies: the great imposters. Lupus 1996; 5:431-5.